Home
Conditions
Lymphoma

Clinical trial condition

Lymphoma

Explore clinical trials studying Lymphoma. Study availability and eligibility vary by location and protocol.

3,651 public trials 849 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma trial results

Completed

A Study of the MALT1 Inhibitor JNJ-67856633 and Ibrutinib in Combination in B-cell NHL and CLL

NCT04876092

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations: Rigshospitalet Copenhagen, Denmark

CHRU de Lille Hopital Claude Huriez Lille, France

Institut Paoli Calmettes Marseille, France

CHU de Nantes hotel Dieu Nantes, France

View Trial Details

Completed

A Study of JNJ-64264681 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

NCT04210219

Conditions: Chronic Disease, Disease Attributes, Hematologic Diseases, +15 more
Locations: Icahn School of Medicine at Mount Sinai New York, United States

Arensia Exploratory Medicine Tbilisi, Georgia

Arensia Exploratory Medicine Chisinau, Moldova

Uniwersyteckie Centrum Kliniczne Gdansk, Poland

View all 15 locations

View Trial Details

Completed

A Study of JNJ-64264681 and JNJ-67856633 in Participants With Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

NCT04657224

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: Stony Brook University Medical Center Stony Brook, New York, United States

Monash Medical Centre Clayton, Australia

Peter MacCallum Cancer Centre Melbourne, Australia

Linear Clinical Research Ltd Nedlands, Australia

View all 28 locations

View Trial Details

Completed

Open, Non-comparative Study to Evaluate the Effectiveness and Safety of the Medical Device KOS® L in Correcting Moderate or Severe Nasolabial Folds

NCT06828224

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Clinica Beyond Dental Timișoara, Timiș County, Romania

View Trial Details

Completed

Trial of Mosunetuzumab (BTCT4465A) as Consolidation Therapy in Participants With Diffuse Large B-Cell Lymphoma Following First-Line Immunochemotherapy and as Monotherapy or in Combination With Polatuzumab Vedotin in Elderly/Unfit Participants With Previously Untreated Diffuse Large B-Cell Lymphoma

NCT03677154

Conditions: Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: University of Alabama at Birmingham School of Medicine Birmingham, Alabama, United States

University of California, Los Angeles (UCLA) - Hematology/Oncology Santa Monica Santa Monica, California, United States

Fort Wayne Medical Institute Fort Wayne, Indiana, United States

University of Maryland Medical Center Baltimore, Maryland, United States

View all 32 locations

View Trial Details

Completed

HyBryte (Synthetic Hypericin) Versus Valchlor (Mechlorethamine) in the Treatment of CTCL

NCT06149247

Conditions: Cutaneous T-Cell Lymphoma/Mycosis Fungoides, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Rochester Skin Lymphoma Medical Group Fairport, New York, United States

View Trial Details

Completed

Pharmacokinetics of Intravaginal, Self-administered Artesunate Vaginal Pessaries Among Women in Kenya

NCT06263582

Conditions: Carcinoma, Carcinoma in Situ, Cervix Cancer, +28 more
Locations: Lumumba Sub-County Hospital Kisumu, Kenya

View Trial Details

Completed

Phase 1-2 MAHCT w/ TCell Depleted Graft w/ Simultaneous Infusion Conventional and Regulatory T Cell

NCT01660607

Conditions: Acute Leukemia, Acute Lymphoblastic Leukemia (ALL), Acute Myelogenous Leukemia, +28 more
Locations: Stanford University School of Medicine Palo Alto, California, United States Palo Alto, California, United States

View Trial Details

Completed

Breast Cancer Risk Investigation in Grown-up Hodgkin Lymphoma Patients Treated With MBVD. Multicenter Retrospective Study on ≥200 Adult Female HL Patients Treated With ≥1 MBVD Cycle (NPLD, Bleomycin, Vinblastine, Dacarbazine). It Investigates Breast Cancer Incidence Post-treatment.

NCT07120217

Conditions: Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
Locations: Not specified

View Trial Details

Completed

Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age

NCT03834688

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Carle Cancer Center Urbana, Illinois, United States

Indiana University Simon Cancer Center Indianapolis, Indiana, United States

St. Joseph Mercy Hospital Cancer Care Center Ann Arbor, Michigan, United States

Mayo Clinic Rochester, Minnesota, United States

View Trial Details

Lymphoma

Lymphoma trial results

Related conditions